Roberts Brandi — SEC Form 4 filings
SEC reporting owner CIK 1516354. 11 Form 4 filings on record with FilingPulse; latest filed 2026-09-14.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-09 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,013 shares, $135,675 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 3,013 shares @ $45.03 ($135,675) in Definium Therapeutics, Inc., filed 2026-06-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | Chief Financial Officer | 6 | — | 1 leg · 3,013 sh · $135,675 | 5 |
| Longboard Pharmaceuticals, Inc. (LBPH) | Executive VP and CFO | 3 | — | — | 9 |
| TFF Pharmaceuticals, Inc. (TFFP) | Director | 2 | — | — | 3 |
Form 4 filings — Roberts Brandi
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2026-08-12 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2026-06-26 | 4 | Definium Therapeutics, Inc. (DFTX) | Sale (S): 3,013 @ $45.03 | EDGAR |
| 2026-06-22 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2026-02-05 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-06-02 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Disposition to issuer (D): 139,380 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 119,700 (derivative) · Disposition to issuer (D): 90,580 (derivative) · Disposition to issuer (D): 15,090 (derivative) · Disposition to issuer (D): 7,900 (derivative) | EDGAR |
| 2024-10-29 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/award (A): 7,900 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | TFF Pharmaceuticals, Inc. (TFFP) | Grant/award (A): 3,165 @ $0 · Grant/award (A): 3,165 (derivative) @ $0 | EDGAR |
| 2024-04-22 | 4 | TFF Pharmaceuticals, Inc. (TFFP) | Grant/award (A): 5,333 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/award (A): 15,090 @ $0 · Grant/award (A): 90,580 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1516354 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →